Acting FDA commissioner calls for independent investigation into approval of Alzheimer's drug
CNN
US Food and Drug Administration Acting Commissioner Dr. Janet Woodcock on Friday requested an investigation by the US Department of Health and Human Services Office of Inspector General into the controversial approval of the Alzheimer's disease drug Aduhelm.
In a letter posted on Twitter, Woodcock said an independent review and assessment should consider interactions between Biogen, the company that makes Aduhelm, and the FDA during the process that led to the June approval of the drug.
The discovery of human remains inside a vehicle found in a Georgia pond may be linked to a New York couple who disappeared in 1980, according to police.
Pat Levin, 95 years young, is wrestling daily with something new and depressing.
Millions more senior citizens and lower-income Americans could obtain coverage for costly anti-obesity drugs under a proposal being unveiled Tuesday by the Biden administration.
Texas is quickly becoming the blueprint for how incoming Trump officials expect to work with states on border security – a stark pivot from recent years when it was the epicenter of a bitter feud between state and federal officials.
Alito and Kagan are sharp-tongued strategic questioners and both keenly aware of which other justices might be in play – open to persuasion – during arguments in a case
It’s been two weeks since Hawaii woman Hannah Kobayashi went missing after she did not board a connecting flight to New York City during a layover at Los Angeles International Airport on November 8.
President-elect Donald Trump on Monday promised massive hikes in tariffs on goods coming from Mexico, Canada and China starting on the first day of his administration.
A judge in California has delayed a scheduled resentencing hearing for Lyle and Erik Menendez at the brothers’ first hearing since they were sentenced to life in prison for murdering their parents in 1989 and the latest step in their bid to regain freedom.
Attorneys for Donald Trump conducted an internal investigation into allegations that one of his top aides, Boris Epshteyn, has sought to gain financially from his influence with Trump and others in the president-elect’s orbit, according to multiple sources familiar with the matter.
The special counsel stressed his decision was not about the strength of his case against Trump
CNN’s 5 Things brings you the news you need to know every morning.